Australia markets closed

Arbutus Biopharma Corporation (ABUS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.6000+0.1100 (+4.42%)
At close: 04:00PM EDT
2.5300 -0.07 (-2.69%)
After hours: 07:19PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 464.88M
Enterprise value 340.65M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)23.69
Price/book (mrq)4.38
Enterprise value/revenue 18.78
Enterprise value/EBITDA -4.80

Trading information

Stock price history

Beta (5Y monthly) 2.04
52-week change 3-13.91%
S&P500 52-week change 329.57%
52-week high 33.1500
52-week low 31.6900
50-day moving average 32.6218
200-day moving average 32.2210

Share statistics

Avg vol (3-month) 3961.67k
Avg vol (10-day) 3649.98k
Shares outstanding 5179.49M
Implied shares outstanding 6179.49M
Float 8115.49M
% held by insiders 123.43%
% held by institutions 144.06%
Shares short (15 Mar 2024) 44.13M
Short ratio (15 Mar 2024) 44.77
Short % of float (15 Mar 2024) 43.00%
Short % of shares outstanding (15 Mar 2024) 42.30%
Shares short (prior month 15 Feb 2024) 43.69M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:5
Last split date 304 Nov 2010

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-956.64%

Management effectiveness

Return on assets (ttm)-28.70%
Return on equity (ttm)-59.99%

Income statement

Revenue (ttm)18.14M
Revenue per share (ttm)0.11
Quarterly revenue growth (yoy)-65.70%
Gross profit (ttm)N/A
EBITDA -76.63M
Net income avi to common (ttm)-72.85M
Diluted EPS (ttm)-0.4400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)126M
Total cash per share (mrq)0.7
Total debt (mrq)1.77M
Total debt/equity (mrq)1.67%
Current ratio (mrq)5.87
Book value per share (mrq)0.62

Cash flow statement

Operating cash flow (ttm)-85.94M
Levered free cash flow (ttm)-51.58M